Company intelligence / Profile preview

PETNET Solutions

Sacramento, California, United Statessiemens-healthineers.com ↗

Ownership: Private
Development stage: Commercial

Overview

PETNET Solutions operates the largest global network of PET radiopharmacies, providing commercial supply of PET tracers for clinical diagnostics, notably including tracers for Alzheimer's Disease and other neurodegenerative diseases. The company reliably delivers PET radiopharmaceuticals to hospitals and imaging centers, with a focus on quality, compliance, and educational support for clients.[1][2]

Therapeutic areas: Neurology
Modalities: Radiopharmaceutical
Industry: Medical Imaging

Drug pipeline

8 assets

flotufolastat F 18

Commercial

Indications: Prostate cancer

7 more assets in the full pipeline.

Request access →

Partnerships

Advanced Accelerator Applications

Beyond the preview

Go deeper on PETNET Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PETNET Solutions.

Explore the full profile